| Title | Lipid Nanoparticles Market to Reach USD 350.5M by 2029 |
|---|
| URL | https://www.prnewswire.com/news-releases/lipid-nanoparticles-market-to-reach-usd-350-5m-by-2029--marketsandmarkets-302248835.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Lipid Nanoparticles Market, Lipid Nanoparticles Market Trends |
|---|
| Meta Description | North America held the largest share in 2023, benefiting from advanced healthcare infrastructure and significant R&D investments. |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projected to rise from USD 135.5 million in 2024 to USD 238.1 million by 2029 at a CAGR of 11.9%. Growth is driven by advancements in LNP-based pharmaceuticals, particularly in anti-cancer and mRNA therapies, though regulatory challenges and formulation issues pose potential constraints. Key opportunities include the demand for advanced drug delivery systems and scalable mRNA vaccines. The market's key players include Avanti Polar Lipids, Merck KGaA, and FUJIFILM Pharmaceuticals, with North America being the leading regional market. The sector is influenced by diverse product segments such as ionizable and PEGylated lipids, with applications spanning COVID-19 and cancer treatments. |
